INMUNE BIO INC. Debt Conversion, Original Debt, Interest Rate of Debt
INMUNE BIO INC. (INMB) reported Debt Conversion, Original Debt, Interest Rate of Debt of 13.00% for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtInterestRateOfDebt · last filed 2024-03-28
- INMUNE BIO INC. debt conversion, original debt, interest rate of debt for fiscal 2023 was 13.00%.
| Period end | Debt Conversion, Original Debt, Interest Rate of Debt 9 month | Debt Conversion, Original Debt, Interest Rate of Debt 12 month |
|---|---|---|
| 2023-12-31 | 13.00% 10-K · filed 2024-03-28 | |
| 2023-09-30 | 13.00% 10-Q · filed 2023-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |